Trellis Bioscience

About:

Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.

Website: http://www.trellisbio.com

Top Investors: Nodenza Venture Partners, Novartis Venture Fund, Morgenthaler Ventures, Easton Capital, CARB-X

Description:

Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.